Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Operating Expenses (2016 - 2026)

InflaRx's Operating Expenses history spans 9 years, with the latest figure at -$8.7 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 38.7% to -$8.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$13.0 billion, a 19.99% increase, with the full-year FY2025 number at $30.0 million, up 115.24% from a year prior.
  • Operating Expenses hit -$8.7 million in Q1 2026 for InflaRx, down from $66.5 million in the prior quarter.
  • Over the last five years, Operating Expenses for IFRX hit a ceiling of $66.5 million in Q4 2025 and a floor of -$53456.5 billion in Q4 2022.
  • Historically, Operating Expenses has averaged -$5895.1 billion across 5 years, with a median of -$16.6 million in 2022.
  • The widest YoY moves for Operating Expenses: up 100.0% in 2023, down 217380906.46% in 2023.
  • Tracing IFRX's Operating Expenses over 5 years: stood at -$53456.5 billion in 2022, then skyrocketed by 100.0% to $46.4 million in 2023, then rose by 17.75% to $54.6 million in 2024, then increased by 21.85% to $66.5 million in 2025, then crashed by 113.12% to -$8.7 million in 2026.
  • Business Quant data shows Operating Expenses for IFRX at -$8.7 million in Q1 2026, $66.5 million in Q4 2025, and -$11.7 million in Q3 2025.